Interpace Biosciences IDXG
OTC IDXG
$6.50 +1.10 (+20.37%)
At close: Oct 23, 2026 · 4:00 PM EDT

Interpace Biosciences (IDXG) Short term Debt (2015 - 2023)

Updated

Interpace Biosciences' Short term Debt came in at $1.5 million for Q2 2023, down 25.0% from $2 million a year earlier and down 31.8% from the prior quarter.

Analysis

Interpace Biosciences (IDXG) Short term Debt (2015 - 2023) Analysis & Trends

At the end of FY2022, Interpace Biosciences' Short term Debt was $2.5 million.

  • The Q2 2023 figure represents the lowest quarterly Short term Debt since Q4 2015.
  • Business Quant data shows IDXG's Short term Debt at $2.2 million (Q1 2023), $2.5 million (Q4 2022) and $2.5 million (Q3 2022) in the three quarters before Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 102.25 Bn 101.69 Bn -
2 Natera 58.01 Bn 53.69 Bn 485.19 Mn
3 Labcorp Holdings 26.62 Bn 24.38 Bn 1.11 Bn
4 Quest Diagnostics 26.61 Bn 24.70 Bn 1.04 Bn
5 Guardant Health 22.59 Bn 18.65 Bn 219.03 Mn
6 Tenet Healthcare 21.62 Bn 12.76 Bn -
7 Fresenius Medical Care AG 12.67 Bn 5.74 Bn 1.52 Bn
8 Encompass Health 12.25 Bn 12.72 Bn -
9 BrightSpring Health Services 11.87 Bn 10.21 Bn 492.75 Mn
10 Interpace Biosciences 180.06 Mn 170.78 Mn 5.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.50 Mn
Mar 31, 2023 2.20 Mn
Dec 31, 2022 2.50 Mn
Sep 30, 2022 2.50 Mn
Jun 30, 2022 2.00 Mn
Sep 30, 2016 3.76 Mn
Jun 30, 2016 3.76 Mn
Mar 31, 2016 2.46 Mn
Dec 31, 2015 1.16 Mn
API Access

Interpace Biosciences Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=IDXG&period=max&api_key=YOUR_API_KEY